Lung Cancer Diagnostics Market Analysis By Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), By Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), And Segment Forecasts To 2024

Table of Content

Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation& scope
4.2 Market size and growth prospects
4.2.1 Market Driver Analysis
4.2.1.1 Rise in awareness about lung cancer symptoms
4.2.1.2 High cigarette consumption
4.2.1.3 Other drivers
4.2.2 Market Restraint Analysis
4.2.2.1 Cost of diagnosis
4.2.2.2 Lack of healthcare infrastructure
4.3 Penetration & growth prospect mapping
4.4 Lung Cancer Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis - Porter’s
4.6肺癌诊断公司市场份额/ competitive landscape, 2015
Chapter 5 Market Categorization 1: Lung Cancer Type Estimates & Trend Analysis
5.1 Lung cancer diagnostics market: Lung cancer type movement analysis
5.2 Small cell lung cancer (SCLC)
5.2.1 Small cell lung cancer diagnostics market, 2013 - 2024 (USD Million)
5.3 Non-small cell lung cancer (NSCLC)
5.3.1 Non-small cell lung cancer diagnostics market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 2: Diagnostic Test Estimates & Trend Analysis
6.1 Lung cancer diagnostics market: Application movement analysis
6.2 Imaging Test
6.2.1 Imaging test market, 2013 - 2024 (USD Million)
6.3 Sputum cytology
6.3.1 Sputum cytology market, 2013 - 2024 (USD Million)
6.4 Biopsy
6.4.1 Biopsy market, 2013 - 2024 (USD Million)
6.5 Molecular tests
6.5.1 Molecular tests market, 2013 - 2024 (USD Million)
6.6 Others
6.6.1 Other diagnostics market, 2013 - 2024 (USD Million)
Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Type & Test
7.1 Lung cancer diagnostics market share by region, 2015 & 2024
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Russia
7.3.2 Germany
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.5 Latin America
7.5.1 Brazil
7.6 MEA
7.6.1 South Africa
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
8.3.1 Roche Diagnostics
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 bioMérieux
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Qiagen N.V.
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Thermo Fisher Scientific
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 Agilent Technologies
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 SanofiS.A.
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives

List of Tables

TABLE 1 North America lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 2 North America lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 3 U.S. lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 4 U.S. lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 5 Canada lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 6 Canada lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 7 Europe lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 8 Europe lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 9 Russia lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 10 Russia lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 11 Germany lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 12 Germany lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 13 Asia Pacific lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 15 China lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 16 China lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 17 India lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 18 India lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 19 Latin America lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 20 Latin America lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 21 Brazil lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 22 Brazil lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 23 MEA lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 24 MEA lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)
TABLE 25 South Africa lung cancer diagnostics market, by type, 2013 - 2024 (USD Million)
TABLE 26 South Africa lung cancer diagnostics market, by test, 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver prevalence analysis (Current & future impact)
FIG. 5 Number of cigarettes smoked per person per year: 2014
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Lung cancer diagnostics market type outlook key takeaways
FIG. 10 Lung cancer diagnostics market: Lung cancer type movement analysis
FIG. 11 Global small cell lung cancer diagnostics market, 2013 - 2024 (USD Million)
FIG. 12 Global non-small cell lung cancer diagnostics market, 2013 - 2024 (USD Million)
FIG. 13 Lung cancer diagnostics market test outlook: Key takeaways
FIG. 14 Lung cancer diagnostics market: Test movement analysis
FIG. 15 Global imaging test market, 2013 - 2024 (USD Million)
FIG. 16 Global sputum cytology market, 2013 - 2024 (USD Million)
FIG. 17 Global biopsy market, 2013 - 2024 (USD Million)
FIG. 18 Global molecular test market, 2013 - 2024 (USD Million)
FIG. 19 Global other diagnostics market, 2013 - 2024 (USD Million)
FIG. 20 Regional market place: Key takeaways
FIG. 21 Regional outlook, 2015 & 2024
FIG. 22 Strategy framework
FIG. 23 Participant categorization